Fundraising Fox

Cirrus Therapeutics, Inc.

Cambridge, US · Founded 2022 · Delaware corporation · 1 known investors

Founders & leadership

Cirrus Therapeutics, Inc. was founded in 2022 by Ying Kai Chan.

YK
Ying Kai ChanFounder
AD
Andrew DickNamed on SEC filing

Board

ACAlexandra Cantley
Alexandra Cantleyin𝕏Board directorManaging Partner at Polaris Partners
KS
Khoo ShihBoard director

Investors · 1

Polaris PartnersreportedBoston · $500K – $5Mvia Alexandra Cantley · board

Reported raises · per SEC filings

Form D private placements

$6.7M disclosed across 1 round · 2025

▶$6.7MraisedAug 2025 · 8 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alexandra CantleyDirector
  • Andrew DickDirector, Promoter
  • Khoo ShihDirector
  • Ying Kai ChanExecutive Officer, Director, Promoter
Offering amount
$15.7M
Amount sold
$6.7M
First sale
Aug 2025
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Cirrus Therapeutics Strengthens Its Position as a Next-Generation Global Ocular Immunology Leader with Singapore Eye Research Institute (SERI) Collaboration and Additional Financingglobenewswire.com · Aug 2026Cirrus Therapeutics Raises $11 M Seed Financing to Advance Novel Ocular Gene Therapy to Reverse Underlying Age-Related Cause of Dry AMDglobenewswire.com · Oct 2025

Frequently asked questions

Who founded Cirrus Therapeutics, Inc.?
Cirrus Therapeutics, Inc. was founded by Ying Kai Chan in 2022.
Who are Cirrus Therapeutics, Inc.'s investors?
Cirrus Therapeutics, Inc.'s investors include Polaris Partners.
How much funding has Cirrus Therapeutics, Inc. raised?
Cirrus Therapeutics, Inc. has disclosed $6.7M raised across 1 round.
Where is Cirrus Therapeutics, Inc. headquartered?
Cirrus Therapeutics, Inc. is headquartered in Cambridge, US.